The impact of ALA (5-aminolevulinic acid)-fluorescence detection on the prognosis of superficial bladder cancer. A 7-year survival analysis;Der stellenwert der ALA-(5-amino-lävulinsäure)- fluoreszenzdetektion für die prognose des oberflächlichen blasenkarzinoms. Eine 1-jahres-überlebensanalyse

Aktuelle Urologie

Volumn 35, Issue 6, 2004, Pages 497-501

  Daniltchenko, D ^a   Riedl, C ^b,c   Koenig, F ^a   Daha, L K ^b   Sachs, M ^a   Schnorr, D ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b GENERAL HOSPITAL LINZ   (Austria)

^c Urologische Universitatsklinik   (Austria)

Author keywords

5 aminolevulinic acid (ALA); Bladder cancer; Fluorescence; Recurrence

Indexed keywords

ARTICLE; BLADDER CANCER; COST OF ILLNESS; CYSTOSCOPY; FLUORESCENCE; FOLLOW UP; HUMAN; STATISTICAL SIGNIFICANCE; SUPERFICIAL CANCER; SURVIVAL; ADULT; AGED; BLADDER TUMOR; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REOPERATION; SENSITIVITY AND SPECIFICITY; TIME; TUMOR RECURRENCE;

AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT;

ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CYSTOSCOPY; FEMALE; FLUORESCENCE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHOTOSENSITIZING AGENTS; PROGNOSIS; PROSPECTIVE STUDIES; REOPERATION; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 8744286794     PISSN: 00017868     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-818544     Document Type: Article

References (17)

1. Baumgartner R, Kriegmair M, Jocham D, Hofstetter A, Huber R, Karg O et al. Photodynamic diagnosis (PDD) of early stage malignancies - Preliminary results in urology and pneumology. Proc SPIE 1992; 1641: 107-112
2. D'Hallewin MA, Bezdetnaya L, Guillemin F. Fluorescence detection of bladder cancer: a review. Eur Urol 2002; 42: 417-425
3. Filbeck T, Pichlmeier U, Knuechel R, Wieland WF, Rossler W. Senkung des Rezidivrisikos oberflächlicher Harnblasenkarzinome mittels 5-Aminolävulinsäure-induzierter Fluoreszenzdiagnostik Resultate einer 5-Jahres-Studie. Urologe A 2003; 42: 1366-1373
4. Filbeck T, Roessler W, Knuechel R, Straub M, Kiel HJ, Wieland WF. 5-aminolevulinic acid-induced fluorescence endoscopy applied at secondary transurethral resection after conventional resection of primary superficial bladder tumors. Urology 1999; 53: 77-81
5. Grimbergen MC, Swol CF van, Jonges TG, Boon TA, Moorselaar RJ van. Reduced specificity of 5-ALA induced fluorescence in photodynamic diagnosis of transitional cell carcinoma after previous intravesical therapy. Eur Urol 2003; 44: 51-56
6. Jichlinski P, Forrer M, Mizeret J, Glanzmann T, Braichotte D, Wagnières G et al. Clinical evaluation of a method for detecting superficial transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following topical application of 5-aminolevulinic acid: preliminary results. Lasers Surg Med 1997; 20: 402-408
7. Klän R, Loy V, Huland H. Residual tumor discovered in routine second transurethral resection in patients with stage T transitional cell carcinoma of the bladder. J Urol 1991; 146: 316-318
8. Köhrmann KU, Woeste M, Kappes J, Rassweiler J, Alken P. Der Wert der transurethralen Nachresektion beim oberflächlichen Harnblasenkarzinom. Akt Urol 1994; 25: 208-213
9. Kriegmair M, Baumgartner R, Knüchel R, Stepp H, Hofstädter F, Hofstetter A. Detection of bladder cancer by 5-aminolävulinic acid induced porphyrin fluorescence. J Urol 1996; 155: 105-110
10. Kurth KH, Bouffioux C, Sylvester R, Meijden AP van der, Oosterlinck W, Brausi M. Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group. Eur Urol 2000; 37 [Suppl 3]: 1-9
11. Miller K, Weißbach L. Leitlinien zur Diagnostik und Therapie des Harnblasenkarzinoms. Urologe A 1998; 37: 440-457
12. Rassweiler JJ, Rahm HJ, Abdel-Salam Y, Hatzinger M. Fluorescence aided transurethral resection of superficial bladder cancer. Does it improve the quality of TUR? Eur Urol 2000; 37 [Suppl]: Abstract-440
13. Riedl C, Plas E, Pflüger H. Fluorescence Detection of Bladder Tumors with 5-Amino-Levulinic Acid. J Endourol 1999; 13: 755-759
14. Riedl CR, Daniltchenko D, Koenig F, Simak R, Loening SA, Pflueger H. Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer. J Urol 2001; 165: 1121-1123
15. Vögeli T, Grimm M, Ackermann R. Prospective study for quality control of TUR of bladder tumors by routine 2nd TUR (Re TUR). J Urol 1998; 159 [Suppl]: 143
16. Wechsel HW, Rosenkranz T, Bichler KH, Petri E. Nach- und Sicherheitsresektion beim oberflächlichen, niedriggradigen Blasenkarzinom. Urologe 1996; A 35 [Suppl 1]: 118
17. Zaak D, Frimberger D, Mueller-Lisse U, Schmeller N, Stiegelmayr A, Frimberger D, Kriegmair M et al. Decrease of early recurrence by means of 5-aminolevulinic induced fluorescence endoscopy in patients with bladder cancer follow up of a randomized phase III trial. J Urol 2001; 165 [Suppl]: 165